Bellicum Pharmaceuticals (BLCM) PT Lowered to $19 at Citi
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Price: $0.62 --0%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Citi lowered its price target on Bellicum Pharmaceuticals (NASDAQ: BLCM) to $19.00 (from $22.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- HCL Technologies (HCLT:IN) PT Lowered to INR1,395 at UBS
- Slate Grocery REIT (SGR-U:CN) (SRRTF) PT Lowered to $8.25 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
